Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | VAC85135 |
| Synonyms | |
| Therapy Description |
VAC85135 is a cancer vaccine comprising a viral vector expressing neoantigens, which may result in the induction of a cytotoxic T-lymphocyte (CTL) response against neoantigen-expressing tumor cells (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| VAC85135 | VAC-85135|VAC 85135 | VAC85135 is a cancer vaccine comprising a viral vector expressing neoantigens, which may result in the induction of a cytotoxic T-lymphocyte (CTL) response against neoantigen-expressing tumor cells (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|